← Mirae Asset Mutual Fund

Mirae Asset Nifty 500 Healthcare ETF

Index/ETF Data as of Oct 2026 Comparing Sep 2026 → Oct 2026
Share: WhatsApp X
Stocks Held
44
Oct 2026
Equity Holdings
₹15.58 Cr
Equity only, excl. debt & cash
Top 5 Weight
38.1%
Moderate
Top 10 Weight
60.4%
High concentration
Changes
43
0 new · 0 exits
Top Sector
Pharmaceuticals & Biotechnology
78.6% of portfolio
Launch Date
27 Jan 2026
0 years old
📋 What Happened This Month Among existing holdings, Laurus Labs Limited saw the biggest increase — now at 6.85% of the portfolio. Max Healthcare Institute Limited was trimmed the most, now at 4.68%. Sun Pharmaceutical Industries Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 78.6%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.
Sector Shift Industry allocation month-over-month
Aug 2026 → Sep 2026
Sector Prev Curr ▼ Delta
Pharmaceuticals & Biotechnology 76.4% 77.8% ▲ +1.4%
Healthcare Services 23.1% 21.7% ▼ -1.4%
Healthcare Equipment & Supplies 0.5% 0.5% ● 0.0%
Sep 2026 → Oct 2026
Sector Prev Curr ▼ Delta
Pharmaceuticals & Biotechnology 77.8% 78.6% ▲ +0.8%
Healthcare Services 21.7% 21.0% ▼ -0.7%
Healthcare Equipment & Supplies 0.5% 0.4% ● -0.1%
↑
Biggest Add
Laurus Labs Limited
+1.13% · now 6.85%
↓
Biggest Trim
Max Healthcare Institute Limited
-0.45% · now 4.68%

What Changed in the Portfolio This Month?

Comparing Sep 2026 → Oct 2026

Sep 2026 → Oct 2026
↑ 13 Increased ↓ 30 Decreased
#StockSectorSep 2026Oct 2026Change
1
Laurus Labs Limited
₹1.07 Cr
Pharmaceuticals & Biotechnology 5.72% 6.85% +1.13%
2
Dr. Reddy's Laboratories Limited
₹93.90 L
Pharmaceuticals & Biotechnology 5.58% 6.03% +0.45%
3
Divi's Laboratories Limited
₹1.42 Cr
Pharmaceuticals & Biotechnology 8.76% 9.08% +0.32%
4
Acutaas Chemicals Ltd
₹23.62 L
Pharmaceuticals & Biotechnology 1.26% 1.52% +0.26%
5
Piramal Pharma Limited
₹16.90 L
Pharmaceuticals & Biotechnology 0.95% 1.08% +0.13%
6
Zydus Lifesciences Limited
₹35.14 L
Pharmaceuticals & Biotechnology 2.14% 2.26% +0.12%
7
Apollo Hospitals Enterprise Limited
₹99.01 L
Healthcare Services 6.24% 6.35% +0.11%
8
Gland Pharma Limited
₹28.08 L
Pharmaceuticals & Biotechnology 1.71% 1.80% +0.09%
9
Cipla Limited
₹88.36 L
Pharmaceuticals & Biotechnology 5.62% 5.67% +0.05%
10
Syngene International Limited
₹8.71 L
Healthcare Services 0.51% 0.56% +0.05%
#StockSectorSep 2026Oct 2026Change
1
Max Healthcare Institute Limited
₹72.88 L
Healthcare Services 5.13% 4.68% -0.45%
2
Sun Pharmaceutical Industries Limited
₹1.52 Cr
Pharmaceuticals & Biotechnology 10.13% 9.77% -0.36%
3
Torrent Pharmaceuticals Limited
₹77.27 L
Pharmaceuticals & Biotechnology 5.24% 4.96% -0.28%
4
Wockhardt Limited
₹17.87 L
Pharmaceuticals & Biotechnology 1.30% 1.15% -0.15%
5
Biocon Limited
₹27.92 L
Pharmaceuticals & Biotechnology 1.91% 1.79% -0.12%
6
Neuland Laboratories Limited
₹19.31 L
Pharmaceuticals & Biotechnology 1.36% 1.24% -0.12%
7
Krishna Institute Of Medical Sciences Limited
₹21.32 L
Healthcare Services 1.48% 1.37% -0.11%
8
GlaxoSmithKline Pharmaceuticals Limited
₹11.75 L
Pharmaceuticals & Biotechnology 0.85% 0.75% -0.10%
9
Lupin Limited
₹55.62 L
Pharmaceuticals & Biotechnology 3.66% 3.57% -0.09%
10
Glenmark Pharmaceuticals Limited
₹39.42 L
Pharmaceuticals & Biotechnology 2.61% 2.53% -0.08%

What Stocks Does This Fund Hold?

44 stocks — Oct 2026

# Stock Sector Cap Weight & Value
1
₹1.52 Cr
Pharmaceuticals & Biotechnology
9.77%
2
₹1.42 Cr
Pharmaceuticals & Biotechnology
9.08%
3
₹1.07 Cr
Pharmaceuticals & Biotechnology
6.85%
4
₹99.01 L
Healthcare Services
6.35%
5
₹93.90 L
Pharmaceuticals & Biotechnology
6.03%
6
₹88.36 L
Pharmaceuticals & Biotechnology
5.67%
7
₹77.27 L
Pharmaceuticals & Biotechnology
4.96%
8
₹72.88 L
Healthcare Services
4.68%
9
₹55.62 L
Pharmaceuticals & Biotechnology
3.57%
10
₹52.91 L
Pharmaceuticals & Biotechnology
3.40%
🏆 Top stocks held by Equity funds
See which stocks all active Equity fund managers are buying — ranked by total value invested
→
🏦 Mirae Asset Mutual Fund — Portfolio & Holdings
See all funds managed by Mirae Asset Mutual Fund — conviction stocks, monthly entries & exits
→

Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.

Found a discrepancy or have feedback? Contact Us — we read every message personally.